A guide to HCPs with basic information about treatment with Jyseleca in RA. The guide contains information about indication, dosing, treatment guidance for special populations, warnings and precautions, treatment initiation checklist, contraindications, interactions, side effects and guidance for monitoring patients. Language: English.
GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV.
© Galapagos Biopharma Norway AS.
Munkedamsvien 59B, 0270 Oslo, Norway, VAT: 927480654MVA. All rights reserved.
NO--JY-202306-00001
GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV.
© Galapagos Biopharma Norway AS.
Munkedamsvien 59B, 0270 Oslo, Norway, VAT: 927480654MVA. All rights reserved.
NO--JY-202306-00001
© Copyright 2021 Galapagos NV
THIS CONTENT IS FOR HEALTHCARE PRACTIONERS ONLY.
DO YOU WORK AS AN NORWEGIAN HEALTHCARE PRACTIONER?
We have sent an email to the following email address: ${userEmail}
Simply follow the password to activate your account
We have sent an email to the following email address: ${userEmail}
Thank you for registering. Please check your e-mail for further instructions.
We have sent an email to the following email address: ${userEmail}
Simply follow the password reset instructions
in the email.
You are about to leave this website and will be redirected to an external website. We are not responsible of that external website’s content. By continuing, you confirm that you have taken note of this.
